References
1         Busse WW, Lemanske RF, Gern JE. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet. 2010;376 : 826–34.
2         Johnston SL, Pattemore PK, Sanderson G, et al.Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995; 310 : 1225.
3         Skevaki C, Karsonova A, Karaulov A, Xie M, Renz H. Asthma-associated risk for COVID-19 development. J Allergy Clin Immunol 2020; 146 : 1295–301.
4       Wang Y, Ao G, Qi X, Xie B. The association between COVID‐19 and asthma: A systematic review and meta‐analysis. Clin Exp Allergy2020; 50 : 1274–7.
5 Mendes NF, Jara CP, Mansour E, Araújo EP, Velloso LA. Asthma and COVID-19: a systematic review. Allergy, Asthma Clin Immunol 2021;17 : 5.
6 Terry PD, Heidel RE, Dhand R. Asthma in Adult Patients with COVID-19: Prevalence and Risk of Severe Disease. Am J Respir Crit Care Med2021; published online Jan 25. DOI:10.1164/rccm.202008-3266oc.
7 Lovinsky-Desir S, Deshpande DR, De A, et al. Asthma among hospitalized patients with COVID-19 and related outcomes. 2020. DOI:10.1016/j.jaci.2020.07.026.
8       Rosenthal JA, Awan SF, Fintzi J, Keswani MSCI A, Ein D. Asthma is associated with increased risk of intubation but not hospitalization or death in coronavirus disease 2019. Ann Allergy, Asthma Immunol2021; 126 : 93–5.
9 Broadhurst R, Peterson R, Wisnivesky JP, et al. Asthma in COVID-19 Hospitalizations: An Overestimated Risk Factor? Ann Am Thorac Soc 2020; 17 . DOI:10.1513/AnnalsATS.202006-613RL.
10 Zhu Z, Hasegawa K, Ma B, et al. Association of asthma and its genetic predisposition with the risk of severe COVID-19. J Allergy Clin Immunol 2020; : 327-329.e4.
11       Myung Yang J, Yong Koh H, Yong Moon S, et al. Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study. 2020. DOI:10.1016/j.jaci.2020.08.008.
12 Skevaki C, Karsonova A, Karaulov A, et al. SARS-CoV-2 infection and COVID-19 in asthmatics: a complex relationship. Nat. Rev. Immunol. 2021; : 1.
13 Jackson DJ, Busse WW, Bacharier LB, et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol 2020; 146 . DOI:10.1016/j.jaci.2020.04.009.
14 Ferastraoaru D, Hudes G, Jerschow E, et al. Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness. J Allergy Clin Immunol Pract 2021; published online Jan. DOI:10.1016/j.jaip.2020.12.045.
15 Lowe HJ, Ferris TA, Hernandez PM, Weber SC. STRIDE: an integrated standards-based translational research informatics platform. 2009; : 391–5.
16 Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2020 www.ginasthma.org (accessed Jan 19, 2021).
17 National Institutes of Health. Clinical Spectrum | COVID-19 Treatment Guidelines. 2020. https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/ (accessed Jan 19, 2021).
18 Chen Y, Gong X, Wang L, Guo J. Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis. medRxiv 2020; published online March 30. DOI:https://doi.org/10.1101/2020.03.25.20043133.
19 Kruglikov I, Shah M, Scherer P. Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral-bacterial interactions. eLife 2020; 9. DOI: 10.7554/eLife.61330.
20 Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, Sohal SS. Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19). J Clin Med 2020; 9 . DOI:10.3390/jcm9030841.
21 Xie G, Ding F, Han L, Yin D, Lu H, Zhang M. The role of peripheral blood eosinophil counts in COVID‐19 patients. Allergy 2020; published online July 13. DOI:10.1111/all.14465.
22 Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol 2020; 146 . DOI:10.1016/j.jaci.2020.04.021.
23 Choi YJ, Park J-Y, Lee HS, et al. Early View Effect of Asthma and Asthma Medication on the Prognosis of Patients with COVID-19. DOI:10.1183/13993003.02226-2020.
24 Schultze A, Walker AJ, MacKenna B, et al. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. Lancet Respir Med2020; 8 : 1106–20.
25 Bloom CI, Drake TM, Docherty AB, et al. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK. Lancet Respir Med 2021; published online March. DOI:10.1016/S2213-2600(21)00013-8.
26 Matsuyama S, Kawase M, Nao N, et al . The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells. Journal of Virology 2020; 95. DOI: 10.1128/JVI.01648-20.
27 Peters M, Sajuthi S, Deford P, et al . COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids. American Journal of Respiratory and Critical Care Medicine 2020; 202. DOI: 10.1164/rccm.202003-0821OC.
28 Finney LJ, Glanville N, Farne H, et al. Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon. 2021. DOI:10.1016/j.jaci.2020.09.034.
29 Carfì A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020; 324 . DOI:10.1001/jama.2020.12603.
30 Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ 2020; published online Aug 11. DOI:10.1136/bmj.m3026.